V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20025363 | 20010785 | 1.61 | 83 | Disease modification (D) | 2017-01-10 | 2016-12-21 | FEC + DOCETAXEL | 02 | N | 20089492 | FEC + DOCETAXEL |
| 20025364 | 20010786 | 1.61 | null | Neo-adjuvant (N) | 2013-06-30 | 2013-07-19 | FEC 100 + DOCETAXEL | 2 | N | 20089509 | FEC + DOCETAXEL |
| 20025365 | 20010786 | null | 71.95 | Neo-adjuvant (N) | 2015-10-22 | 2015-10-30 | FEC 100 + DOCETAXEL | N | N | 20089509 | FEC + DOCETAXEL |
| 20025366 | 20108614 | 1.63 | 79.65 | Adjuvant (A) | 2016-11-20 | 2016-11-25 | FEC + DOCETAXEL | 02 | N | 20089522 | FEC + DOCETAXEL |
| 20025367 | 20010787 | 1.54 | 60 | Adjuvant (A) | 2017-06-25 | 2017-06-27 | FEC + DOCETAXEL | 2 | Y | 20089523 | FEC + DOCETAXEL |
| 20025368 | 20010787 | 1.62 | 67.1 | Adjuvant (A) | 2013-04-24 | 2013-05-10 | FEC 100 + DOCETAXEL | N | null | 20089523 | FEC + DOCETAXEL |
| 20025369 | 20010787 | null | null | Adjuvant (A) | 2016-01-09 | 2016-01-22 | FEC + DOCETAXEL | null | N | 20089523 | FEC + DOCETAXEL |
| 20025370 | 20010788 | 1.64 | 90 | Neo-adjuvant (N) | 2014-12-30 | 2015-01-07 | FEC + DOCETAXEL | 02 | null | 20089535 | FEC + DOCETAXEL |
| 20025371 | 20010789 | 1.66 | 74.9 | Adjuvant (A) | 2015-03-18 | 2015-03-18 | FEC + DOCETAXEL | 02 | N | 20089540 | FEC + DOCETAXEL |
| 20025372 | 20010789 | 1.65 | 83.8 | Adjuvant (A) | 2016-03-08 | 2016-03-08 | FEC + DOCETAXEL | N | N | 20089540 | FEC + DOCETAXEL |
| 20025373 | 20010790 | 1.71 | 63.6 | Not known (9) | 2015-08-29 | 2015-09-10 | FEC + DOCETAXEL | 02 | N | 20089542 | FEC + DOCETAXEL |
| 20025374 | 20010791 | 1.74 | 53.2 | Adjuvant (A) | 2015-11-10 | 2015-11-13 | FEC + DOCETAXEL | 02 | null | 20089550 | FEC + DOCETAXEL |
| 20025375 | 20010791 | 1.65 | 62.3 | Adjuvant (A) | 2014-03-17 | 2014-03-28 | FEC + DOCETAXEL | 2 | N | 20089550 | FEC + DOCETAXEL |
| 20025376 | 20010791 | 1.65 | 123.1 | null | 2013-11-22 | 2013-12-03 | FEC 100 + DOCETAXEL | 02 | N | 20089550 | FEC + DOCETAXEL |
| 20025377 | 20010792 | 1.54 | null | Adjuvant (A) | 2017-03-03 | 2017-03-11 | FEC 100 + DOCETAXEL | N | N | 20089557 | FEC + DOCETAXEL |
| 20025378 | 20010793 | 1.73 | 63.3 | Adjuvant (A) | 2016-05-31 | 2016-06-15 | FEC + DOCETAXEL | N | N | 20089558 | FEC + DOCETAXEL |
| 20025379 | 20010793 | 1.73 | 59 | Curative (C) | 2014-04-22 | 2014-04-30 | FEC 100 + DOCETAXEL | 02 | N | 20089558 | FEC + DOCETAXEL |
| 20025380 | 20010793 | 1.61 | 66.2 | Not known (9) | 2017-05-02 | 2017-05-02 | FEC + DOCETAXEL | 02 | null | 20089558 | FEC + DOCETAXEL |
| 20025381 | 20010794 | null | 64.1 | Neo-adjuvant (N) | 2016-03-02 | 2016-03-24 | FEC + DOCETAXEL | N | N | 20089561 | FEC + DOCETAXEL |
| 20025382 | 20010794 | 1.7 | 83.6 | Neo-adjuvant (N) | 2017-12-30 | 2017-12-30 | FEC + DOCETAXEL | 02 | N | 20089561 | FEC + DOCETAXEL |
| 20025383 | 20010794 | 1.61 | 64 | Adjuvant (A) | 2017-06-22 | 2017-06-22 | FEC + DOCETAXEL | 2 | N | 20089561 | FEC + DOCETAXEL |
| 20025384 | 20010794 | 1.68 | null | Curative (C) | 2014-04-09 | 2014-04-23 | FEC + DOCETAXEL | N | N | 20089561 | FEC + DOCETAXEL |
| 20025385 | 20010795 | 1.61 | 57.3 | Adjuvant (A) | 2013-10-18 | 2013-10-18 | FEC + DOCETAXEL | 2 | N | 20089566 | FEC + DOCETAXEL |
| 20025386 | 20010795 | null | null | Adjuvant (A) | 2015-06-27 | 2015-07-13 | FEC 100 + DOCETAXEL | N | null | 20089566 | FEC + DOCETAXEL |
| 20025387 | 20010795 | 1.58 | 63.6 | Neo-adjuvant (N) | 2015-05-21 | 2015-05-24 | FEC + DOCETAXEL | 02 | N | 20089566 | FEC + DOCETAXEL |
| 20025388 | 20010796 | 1.64 | 84 | Adjuvant (A) | 2017-05-25 | 2017-05-27 | FEC + DOCETAXEL | 01 | N | 20089583 | FEC + DOCETAXEL |
| 20025389 | 20071301 | 1.68 | 66.6 | Not known (9) | 2015-10-17 | 2015-10-17 | FEC + DOCETAXEL | 02 | N | 20089586 | FEC + DOCETAXEL |
| 20025390 | 20071301 | 1.74 | 78.2 | Adjuvant (A) | 2013-12-09 | 2013-12-09 | FEC + DOCETAXEL | 02 | null | 20089586 | FEC + DOCETAXEL |
| 20025391 | 20010797 | 1.65 | 81 | Neo-adjuvant (N) | 2015-10-08 | 2015-10-29 | FEC 100 + DOCETAXEL | 2 | N | 20089602 | FEC + DOCETAXEL |
| 20025392 | 20010797 | 1.65 | 103 | Adjuvant (A) | 2015-02-12 | 2015-02-12 | FEC + DOCETAXEL | 02 | N | 20089602 | FEC + DOCETAXEL |
| 20025393 | 20010797 | 1.72 | 60.7 | Adjuvant (A) | 2016-09-30 | 2016-10-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20089602 | FEC + DOCETAXEL |
| 20025394 | 20010798 | 1.57 | 87.3 | Adjuvant (A) | 2013-11-19 | 2013-11-20 | FEC 100 + DOCETAXEL | 02 | N | 20089612 | FEC + DOCETAXEL |
| 20025395 | 20010799 | 1.57 | 77.1 | Adjuvant (A) | 2018-02-16 | 2018-02-17 | FEC 100 + DOCETAXEL | 02 | N | 20089615 | FEC + DOCETAXEL |
| 20025396 | 20010799 | 1.53 | 86.2 | Adjuvant (A) | 2017-07-15 | 2017-07-26 | FEC 100 + DOCETAXEL | 02 | N | 20089615 | FEC + DOCETAXEL |
| 20025397 | 20010800 | 1.6 | null | Adjuvant (A) | 2015-01-12 | 2015-01-26 | FEC + DOCETAXEL | N | N | 20089623 | FEC + DOCETAXEL |
| 20025398 | 20010800 | 1.62 | 82 | Adjuvant (A) | 2017-03-29 | 2017-05-26 | FEC + DOCETAXEL | N | N | 20089623 | FEC + DOCETAXEL |
| 20025399 | 20010800 | null | 70 | Neo-adjuvant (N) | 2014-02-04 | 2014-02-04 | FEC + DOCETAXEL | N | N | 20089623 | FEC + DOCETAXEL |
| 20025400 | 20010800 | 1.61 | 85.8 | Adjuvant (A) | null | 2013-09-19 | FEC + DOCETAXEL | N | N | 20089623 | FEC + DOCETAXEL |
| 20025401 | 20010801 | 1.59 | 100.3 | Adjuvant (A) | 2016-05-05 | 2016-05-14 | FEC + DOCETAXEL | N | N | 20089638 | FEC + DOCETAXEL |
| 20025402 | 20010801 | 1.65 | 75.4 | Adjuvant (A) | 2015-04-02 | 2015-04-09 | FEC + DOCETAXEL | 02 | N | 20089638 | FEC + DOCETAXEL |
| 20025403 | 20010802 | null | 100 | Adjuvant (A) | 2017-10-29 | 2017-11-05 | FEC + DOCETAXEL | N | N | 20089652 | FEC + DOCETAXEL |
| 20025404 | 20010803 | null | 57.9 | Neo-adjuvant (N) | 2013-08-20 | 2013-09-07 | FEC + DOCETAXEL | N | N | 20089654 | FEC + DOCETAXEL |
| 20025405 | 20010803 | 1.68 | null | null | 2015-12-26 | 2015-12-27 | FEC 100 + DOCETAXEL | N | null | 20089654 | FEC + DOCETAXEL |
| 20025406 | 20010803 | 1.64 | 132 | Adjuvant (A) | 2014-12-23 | 2014-12-30 | FEC + DOCETAXEL | 02 | null | 20089654 | FEC + DOCETAXEL |
| 20025407 | 20010804 | 1.62 | null | Neo-adjuvant (N) | 2015-06-26 | 2015-07-04 | FEC + DOCETAXEL | N | N | 20089667 | FEC + DOCETAXEL |
| 20025408 | 20010805 | null | 75 | Adjuvant (A) | 2017-11-19 | 2017-12-09 | FEC + DOCETAXEL | N | null | 20089668 | FEC + DOCETAXEL |
| 20025409 | 20010805 | 1.56 | 87 | Curative (C) | 2014-05-24 | 2014-05-28 | FEC + DOCETAXEL | 02 | Y | 20089668 | FEC + DOCETAXEL |
| 20025410 | 20010806 | 1.59 | 65.5 | Adjuvant (A) | 2017-08-22 | 2017-08-22 | FEC 100 + DOCETAXEL | 2 | N | 20089673 | FEC + DOCETAXEL |
| 20025411 | 20010806 | 1.6 | 72 | Adjuvant (A) | 2014-12-21 | 2014-12-21 | FEC + DOCETAXEL | 02 | N | 20089673 | FEC + DOCETAXEL |
| 20025412 | 20010807 | null | 99.8 | Adjuvant (A) | 2013-11-24 | 2013-12-16 | FEC + DOCETAXEL | N | N | 20089677 | FEC + DOCETAXEL |